0.08%| Prev Close: | 3.06 |
|---|---|
| Open: | 3.15 |
| Bid: | 2.98 x 100 |
| Ask: | N/A |
| 1y Target Est: | 5.04 |
| Beta: | 1.35 |
| Next Earnings Date: | N/A |
| Day's Range: | 3.11 - 3.18 |
|---|---|
| 52wk Range: | 2.26 - 5.00 |
| Volume: | 260,091 |
| Avg Vol (3m): | 164,871 |
| Market Cap: | 184.71M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.35 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- InPlay: Pluristem Therapeutics announced that Katherina Reiche & Hans-Dieter Volk met; new opportunities discussed to strengthen collaborative relationships using pluristem's placental expanded cellsBriefing.com(Wed 8:17AM EDT)
- PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Wed 8:03AM EDT)
- Pluristem Welcomes Parliamentary State Secretary of the German Federal Ministry for Environmental, Nature Conservation and Nuclear Safety and the Chairman of the Charite Berlin-Brandenburg Center for Regenerative TherapiesGlobeNewswire(Wed 5:30AM EDT)
- A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013at Seeking Alpha(Mon May 20)
- Cloning: A Stem Cell Revolution?at Motley Fool(Sun May 19)
- PLURISTEM THERAPEUTICS INC FinancialsEDGAR Online Financials(Tue May 14)
- 3 Healthcare Stock Stories For Monday Investment Wellnessat Wall St. Cheat Sheet(Mon May 13)
- Pluristem Therapeutics' PLX cells may be effective in treating preeclampsiaat theflyonthewall.com(Mon May 13)
- Preclinical Research Shows PLX Cells May be Effective in Treating PreeclampsiaGlobeNewswire(Mon May 13)
- PLURISTEM THERAPEUTICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed May 8)
- Pluristem Therapeutics announces Phase 1 trial to study PLX-PAD cellsat theflyonthewall.com(Wed May 8)
- Pluristem Carving Out Distinct Niche in Orthopedic Medicine With New Clinical Trials in Rotator Cuff RepairMarketwired(Wed May 8)
- Pluristem Develops PLX-RAD Cells for Use in HematologyGlobeNewswire(Tue May 7)
- U.S. judge gives onetime 'King of Biotech' four years in prisonat Reuters(Thu May 2)
- United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapyat Seeking Alpha(Tue Apr 30)
Press Releases
- Pluristem Welcomes Parliamentary State Secretary of the German Federal Ministry for Environmental, Nature Conservation and Nuclear Safety and the Chairman of the Charite Berlin-Brandenburg Center for Regenerative TherapiesGlobeNewswire(Wed 5:30AM EDT)
- Preclinical Research Shows PLX Cells May be Effective in Treating PreeclampsiaGlobeNewswire(Mon May 13)
- Pluristem Carving Out Distinct Niche in Orthopedic Medicine With New Clinical Trials in Rotator Cuff RepairMarketwired(Wed May 8)
Must Read
- HP's 2nd-qtr report shows signs of further decay but offers hope of recovery; stock soarsThe Canadian Press(Wed 3:09PM EDT)
- HP raises 2013 outlook as Whitman's plan takes holdReuters(Wed 2:52PM EDT)
- Clearwire, shareholders brace for fight over Sprint bidReuters(Wed 2:49PM EDT)
- First lady lauds preservation of slave quarters near White House as vital to 'national memory'The Canadian Press(Wed 1:14PM EDT)
- Wall Street headed for a solid open ahead of speech by Ben BernankeThe Canadian Press(Wed 1:12PM EDT)